ONCOLYTICS BIOTECH INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ONCOLYTICS BIOTECH INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $6.77M, a 287.80% increase year-over-year.
- ONCOLYTICS BIOTECH INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $7.61M, a 82.02% increase year-over-year.
- ONCOLYTICS BIOTECH INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $1.75M.
- ONCOLYTICS BIOTECH INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $4.18M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $6.77M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $7.61M 10-Q · filed 2026-08-12 | |
| 2025-06-30 | $1.75M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $4.18M 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |